Clinical Trial

Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 16, 2022 (before its estimated June 30, 2023 completion). Its status may not reflect the trial's current state.
Summary
Objective: The adoption of Enhanced Recovery Surgery programs in lung resection is relatively recent with limited outcome data. This study aimed to determine the impact of an Enhanced Recovery Surgery pathway on short- term and long- term results in patients undergoing lung resection for primary lung cancer. Methods: A Randomized Controlled Trial was designed to collect the perioperative data on consecutive patients undergoing lung resection for primary lung cancer. Patients will be randomizely assigned to the ERAS- Group and Control- Group. Short-term and long- term effect will be compared between the two groups.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2020-06-27.
Trial Details
NCT Number NCT04451473
Lead Sponsor The Second Hospital of Shandong University
Conditions Lung Cancer, Surgery, ERAS
Enrollment 350 participants
Start Date 2019-10-08
Primary Completion 2023-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2022-11-16